trump glp 1 announcement drug price deal: Burning questions after Lilly, Novo agreement The Trump administration announced price
Description
This includes integrating the latest clinical trial data and delving into potential signaling pathways and pharmacological mechanisms
GLP-1s arent just changing waistlines theyre reshaping entire healthcare cost models
Regarding renal effects, the evidence of SGLT2is in preventing kidney failure is more abundant than for GLP-1RAs, which showed a beneficial effect on albuminuria but not on hard kidney endpoints
#glp1 #diabetes #medication #T2DM | 28 comments on LinkedIn
You've heard the buzz about semaglutide and tirzepatide for weight loss, but let's clear up the myths
